Figure 1.
Overall survival. (A) +, ER persistent positivity; + to -, ER loss in expression; -, ER persistent negativity; - to +, ER gains in expression; (B) +, PR persistent positivity; + to -, PR loss in expression; -, PR persistent negativity; - to +, PR gains in expression; (C) Group1, HR+/HER2−/+ to HR+/HER2−/+; Group 2, HR+/HER2−/+ to HR−/HER2−/+; Group 3, HR−/HER2−to HR−/HER2−; Group 4, HR−/HER2−/+ to HR+/HER2−/+.